← Leaderboards
Iftikhar J Kullo
Mayo Clinic Coll Of Medicine, Rochester
$21,946,679
Attributed
$30,798,435
Total exposure
11
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.3M · FY2005–24$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$30,798,435 · 11
By mechanism
U01$21,362,318 · 3
R01$7,848,431 · 4
K24$590,352 · 1
K23$587,736 · 1
R21$232,776 · 1
M01$176,822 · 1
Top collaborators
- Richard R Sharp11 shared
- Christopher G Chute6 shared
- Stephen Norman Thibodeau5 shared
- Daniel J. Schaid4 shared
Most similar at Mayo Clinic Coll Of Medicine, Rochester
Same institution · by research overlap
- Christi A Patten$13,240,286
- Michael D. Jensen$31,797,592
- Daniel J. Schaid$10,676,578
- Christopher G Chute$29,045,184
- L. Joseph Melton$2,428,789
Others in their field
Top investigators on “Genomics”
- Eric S Lander · Whitehead Institute For Biomedical Res$790,826,794
- Richard A Gibbs · Baylor College Of Medicine$661,700,875
- Richard K. Wilson · Washington University$497,388,134
- Leonard Freedman · Leidos Biomedical Research, Inc.$405,398,682
- David Heimbrook · Leidos Biomedical Research, Inc.$333,649,126
- Stacey Gabriel · Massachusetts Institute Of Technology$331,896,891
Research focus
GenomicsVariantClinicCohortBaseGeneticElectronic Health RecordLinkFamilyGenotypeCostCoronary Heart DiseasePublic HealthGenesParticipantResourcesRisk FactorsReportingPhenotypeMedicineData SetGenomic MedicineFuturePharmaceutical Preparations
Grant awards (56)
EHR-based Genomic Discovery and Implementation$907,201
U01 · FY2024 · HG · contact PI
GEMINEA: Genomic Medicine for Individuals from East Africa$847,553
R01 · FY2024 · HG · contact PI
Polygenic Risk of Disease in Populations of Diverse Ancestry$592,026
U01 · FY2024 · HG · contact PI
EHR-based Genomic Discovery and Implementation$1,136,925
U01 · FY2023 · HG · contact PI
Polygenic Risk of Disease in Populations of Diverse Ancestry$604,108
U01 · FY2023 · HG · contact PI
EHR-based Genomic Discovery and Implementation (Bioethics Supplement)$211,880
U01 · FY2023 · HG · contact PI
EHR-based Genomic Discovery and Implementation (Supplement)$188,752
U01 · FY2023 · HG · contact PI
EHR-based Genomic Discovery and Implementation (Pediatric Participants Supplement)$145,327
U01 · FY2023 · HG · contact PI
EHR-based Genomic Discovery and Implementation$1,255,885
U01 · FY2022 · HG · contact PI
Polygenic Risk of Disease in Populations of Diverse Ancestry$685,446
U01 · FY2022 · HG · contact PI
EHR-based Genomic Discovery and Implementation$1,273,048
U01 · FY2021 · HG · contact PI
Polygenic Risk of Disease in Populations of Diverse Ancestry$685,446
U01 · FY2021 · HG · contact PI
Patient-Oriented Research in Genomic Discovery and Implementation$118,070
K24 · FY2021 · HL · contact PI
EHR-based Genomic Discovery and Implementation$1,085,761
U01 · FY2020 · HG · contact PI
EHR-Based Strategies to Improve Outcomes in Familial Hypercholesterolemia$638,566
R01 · FY2020 · HL · contact PI
Genomic Basis of Susceptibility to COVID-19 Infection and its Complications$282,848
U01 · FY2020 · HG · contact PI
Patient-Oriented Research in Genomic Discovery and Implementation$118,070
K24 · FY2020 · HL · contact PI
EHR-based Genomic Discovery and Implementation$826,601
U01 · FY2019 · HG · contact PI
EHR-Based Strategies to Improve Outcomes in Familial Hypercholesterolemia$675,136
R01 · FY2019 · HL · contact PI
Patient-Oriented Research in Genomic Discovery and Implementation$118,070
K24 · FY2019 · HL · contact PI
EHR-based Genomic Discovery and Implementation$831,652
U01 · FY2018 · HG · contact PI
EHR-Based Strategies to Improve Outcomes in Familial Hypercholesterolemia$653,490
R01 · FY2018 · HL · contact PI
Patient-Oriented Research in Genomic Discovery and Implementation$118,071
K24 · FY2018 · HL · contact PI
EHR-based Genomic Discovery and Implementation$840,645
U01 · FY2017 · HG · contact PI
EHR-Based Strategies to Improve Outcomes in Familial Hypercholesterolemia$520,081
R01 · FY2017 · HL · contact PI
Patient-Oriented Research in Genomic Discovery and Implementation$118,071
K24 · FY2017 · HL · contact PI
EHR-based Genomic Discovery and Implementation$98,698
U01 · FY2017 · HG · contact PI
EHR-based Genomic Discovery and Implementation$849,369
U01 · FY2016 · HG · contact PI
EHR-based Genomic Discovery and Implementation$233,600
U01 · FY2016 · HG · contact PI
EHR-based Genomic Discovery and Implementation$859,901
U01 · FY2015 · HG · contact PI
EMR Phenotype and Community Engaged Genomic Associations$1,146,618
U01 · FY2014 · HG · contact PI
EMR Phenotype and Community Engaged Genomic Associations$951,710
U01 · FY2013 · HG · contact PI
EMR Phenotype and Community Engaged Genomic Associations$168,421
U01 · FY2013 · HG · contact PI
Plasma Osteoprotegerin and Adverse Outcomes in CHD Patients$113,526
R21 · FY2013 · HL · contact PI
EMR Phenotype and Community Engaged Genomic Associations$773,313
U01 · FY2012 · HG · contact PI
EMR Phenotype and Community Engaged Genomic Associations$279,834
U01 · FY2012 · HG · contact PI
Plasma Osteoprotegerin and Adverse Outcomes in CHD Patients$119,250
R21 · FY2012 · HL · contact PI
EMR Phenotype and Community Engaged Genomic Associations$788,498
U01 · FY2011 · HG · contact PI
Determinants of arterial function in hypertension$739,416
R01 · FY2010 · HL · contact PI
Determinants of arterial function in hypertension$740,241
R01 · FY2009 · HL · contact PI
Proteomic Markers of Arteriosclerosis$874,844
U01 · FY2008 · HL · contact PI
Proteomic Markers of Arteriosclerosis$870,135
U01 · FY2007 · HL · contact PI
Biomarkers of Peripheral Arterial Disease$603,185
R01 · FY2007 · HL · contact PI
Functional Arterial Changes in Atherogenesis$96,984
K23 · FY2007 · RR · contact PI
Proteomic Markers of Arteriosclerosis$979,134
U01 · FY2006 · HL · contact PI
Biomarkers of Peripheral Arterial Disease$607,708
R01 · FY2006 · HL · contact PI
Functional Arterial Changes in Atherogenesis$96,984
K23 · FY2006 · RR · contact PI
Proteomic Markers of Arteriosclerosis$934,692
U01 · FY2005 · HL
Biomarkers of Peripheral Arterial Disease$611,269
R01 · FY2005 · HL
Functional Arterial Changes in Atherogenesis$127,926
K23 · FY2005 · RR
FUNCTIONAL ARTERIAL CHANGES IN ATHEROGENESIS$105,677
M01 · FY2005 · RR
Biomarkers of Peripheral Arterial Disease$600,643
R01 · FY2004 · HL
Functional Arterial Changes in Atherogenesis$136,566
K23 · FY2004 · RR
Functional Arterial Changes in Atherogenesis$71,145
M01 · FY2004 · RR
Biomarkers of Peripheral Arterial Disease$611,143
R01 · FY2003 · HL
Functional Arterial Changes in Atherogenesis$129,276
K23 · FY2003 · RR